Skip to main content
. 2018 Mar 20;23(4):783–789. doi: 10.1007/s10147-018-1268-5

Table 3.

Treatment in the 27 NHL patients with LM

Intrathecal and other CNS-directed therapies Value
Drugs of intrathecal therapy
 MTX 27 (100%)
 Ara-C 18 (67%)
Route of administration of i.t. therapy
 Lumbar puncture 18 (67%)
 Intraventricular (Ommaya reservoir) 9 (33%)
Frequency of administration of i.t. therapy in induction phase
 2–3 times per week 19 (70%)
 Weekly 8 (30%)
Radiotherapy
 Whole brain radiotherapy 4 (15%)
 Cranial and spinal radiotherapy 6 (22%)

i.t. therapy intrathecal therapy